Established in 2005, the Life Sciences Institute Leadership Council has been a pivotal source of vision and innovation, significantly shaping the trajectory of the LSI since inception. The council comprises a diverse group of leaders from across the life sciences sector who share a steadfast belief in LSI's potential as a catalyst for fundamental scientific discovery.
Members
Rajesh Alva, CEO and CIO, Avtar Investments
L. Kay Chandler, Retired Partner, Cooley LLP
Richard Douglas, Ph.D., Board of Directors, Novavax Inc.; Advisor, Red Sky Partners
James Flynn, Partner, Deerfield Management Company
Nikki Hadas, Chief Legal Officer and Advisor
Lawrence G. Hamann, Ph.D., Co-Founder, President and CEO, Interdict Bio
Corey M. Horowitz, Chairman and CEO, Network-1
Christopher J. Kirk, Ph.D., CEO, Kezar Life Sciences
Justin E. Klein, Partner, Benesch
David E. Kroin, Founder and CIO, Deep Track Capital
Shiraz Ladiwala, Former Vice President, Strategy and Corporate Development, Thermo Fisher Scientific
Bruce Leuchter, M.D., President and CEO, Neurvati Neurosciences
Greg Margolies, Senior Partner and Head of Capital Markets Group, Ares Management LLC
Joel F. Martin, Ph.D., Independent Consultant; Former Managing Director and Chief Business Officer, La Jolla Institute for Immunology
Paul M. Meister, Co-Founder, Liberty Lane Partners LLC
Meera Nathan, Ph.D., Pharma Industry Leader and Advisor
Roger Newton, Ph.D., Founder, Executive Chairman and Chief Scientific Officer, Esperion Therapeutics
John E. Osborn, Senior Advisor, Hogan Lovells
Julia C. Owens, Ph.D., Biotech CEO and Advisor
Atul Pande, M.D., Chief Medical Advisor, PureTech Health
Craig C. Parker, CEO, Surrozen
Liam Ratcliffe, M.D., Ph.D., Head of Biotechnology, Access Industries
Terry Rosen, Ph.D., CEO, Arcus Biosciences
Joseph Schwarz, M.D., Former U.S. Representative, 7th Congressional District, Michigan
Matthew C. Smith, Ph.D., Co-Founder and Director, Tornado Bio Inc.
Michael Staebler, Former Partner, Pepper Hamilton LLP
Burton Sutker, M.D., Retired Radiologist, St. Clare’s Health System
David R. Walt, Ph.D., Core Faculty Member, Wyss Institute at Harvard University; Hansjörg Wyss Professor of Biologically Inspired Engineering, Harvard Medical School; Professor, Brigham and Women’s Hospital; Howard Hughes Medical Institute Professor; Founder, Illumina Inc. and Quanterix Corp.
Wendell Wierenga, Ph.D., Independent Consultant; Former CEO and R&D leader in Biotech and Pharma
Steve Worland, Ph.D., President, CEO and Director, eFFECTOR Therapeutics Inc.